Telehealth is reshaping how medication-assisted treatment (MAT) addresses opioid use disorder (OUD).
By offering virtual care options, it removes barriers like long commutes, rigid schedules, and childcare conflicts. This flexibility improves patient retention and access, especially for rural and underserved populations.
Studies show telehealth MAT achieves comparable or better outcomes than in-person care, with high medication adherence and reduced missed appointments.
Key points:
Improved Access: Telehealth connects patients to care, especially in rural areas or for those with limited mobility.
Retention Boost: Virtual appointments reduce logistical challenges, helping patients stay in treatment longer.
Regulatory Support: New rules allow telehealth providers to prescribe OUD medications with safeguards.
Integrated EHR Systems: Tools like Opus Behavioral Health EHR streamline care coordination, compliance, and documentation.
While challenges like technology access and pharmacy limitations remain, telehealth MAT is proving to be a practical solution for combating the opioid crisis.
One of the toughest challenges in treating opioid use disorder (OUD) is keeping patients engaged long enough for treatment to make a real difference.
Telehealth has shown it can tackle many of the hurdles - both logistical and emotional - that often lead to patients dropping out of medication-assisted treatment (MAT) programs.
By improving retention, telehealth helps create better clinical outcomes and offers safer, more adaptable treatment options.
Recent research, particularly after the COVID-19 Public Health Emergency highlights how telehealth can match or even surpass the outcomes of in-person care. For example, telehealth has been linked to higher completion rates for medication for opioid use disorder (MOUD)
visits [1].
One standout example comes from the University of Maryland’s tele-buprenorphine program. Between June 2020 and May 2025, the program treated 842 patients across 1,321 episodes.
The results? A 99.5% medication adherence rate, an average retention of 66 days, and only 3% of patients discharged for issues like medication diversion or hoarding [3].
"Telemedicine is a highly feasible and scalable model for delivering evidence-based MOUD in rural jails... programs can successfully reach high-risk individuals who lack access to community-based care." - Annabelle M. Belcher, PhD, University of Maryland School of Medicine [3]
These impressive outcomes are closely linked to telehealth’s ability to minimize time demands and reduce disruptions in care.
Traditional in-person programs, such as methadone clinics, often require daily attendance, which can eat up 3 to 6 hours of a patient’s day [1].
Telehealth, on the other hand, focuses on the clinical appointment itself, cutting down on wasted time. Plus, missed appointments in traditional settings often mean starting treatment over from scratch, whereas telehealth helps maintain continuity by avoiding such setbacks [1].
Telehealth’s advantages go even further for underserved groups, removing many of the financial and logistical roadblocks they face.
For rural patients, accessing in-person MAT can be a major challenge. Local providers may not accept Medicaid, leaving low-income patients with limited choices [1]. Telehealth bridges this gap, connecting patients with qualified prescribers while also cutting down on travel-related costs like gas and lost wages.
For those juggling disabilities, caregiving responsibilities, or legal obligations, telehealth’s flexibility can be a game-changer for staying in treatment [1][2].
A 2026 study from British Columbia found that 59.3% of individuals with OUD had used virtual appointments. Many participants described telehealth as a relief from the physical and logistical burdens of in-person care [2].
Telehealth MAT vs. In-Person MAT: Key Outcomes & Features
Emerging evidence highlights how telehealth improves clinical outcomes and bolsters patient safety, building on its ability to enhance engagement and retention.
Studies reveal that medication-assisted treatment (MAT) delivered via telehealth achieves results comparable to, or even better than, traditional in-person care [1].
According to Substance Abuse Treatment, Prevention, and Policy, "Studies of post-COVID policies are demonstrating comparable or improved OUD patient clinical outcomes via telehealth compared to in-person care, including increased completed MOUD visits and provider availability" [1].
One key advantage of telehealth is its ability to integrate treatment into patients' daily lives by eliminating travel time and reducing missed appointments.
However, challenges like limited buprenorphine availability at pharmacies can sometimes complicate prescription fulfillment [1].
Evidence supports the safety of telehealth MAT, with data showing low rates of medication diversion. This aligns with earlier findings that MAT via telehealth can be delivered responsibly [3].
To formalize these practices, the DEA and HHS have introduced a final rule, effective February 18, 2025, that extends telemedicine flexibilities for opioid use disorder (OUD) treatment under an exception to the 2008 Ryan Haight Act.
This rule allows practitioners to prescribe an initial six-month supply of OUD medications via telemedicine, provided they follow specific safeguards.
These include mandatory Prescription Drug Monitoring Program (PDMP) checks, pharmacist identity verification before dispensing, and allowances for audio-only consultations when needed [4].
"The purpose of this regulation is to prevent lapses of care by continuing some of the telemedicine flexibilities that currently exist for those patients seeking treatment for opioid use disorder." - Drug Enforcement Administration (DEA) [4]
To ensure compliance and patient safety, providers must conduct thorough PDMP reviews and maintain detailed documentation for every telehealth encounter.
Integrated tools, such as Opus Behavioral Health EHR, streamline this process by simplifying documentation and ensuring adherence to safety protocols. These systems support consistent monitoring and compliance, making it easier for providers to navigate the evolving regulatory landscape.
MAT programs use a range of telehealth approaches to meet the needs of different clinical environments.
One widely used method is the fully virtual model, where every aspect of care - such as buprenorphine induction and ongoing maintenance - is conducted remotely. This eliminates the need for an initial in-person visit. It’s a game-changer for patients in rural areas, who might otherwise face long drives - anywhere from 60 to 200 miles - to access treatment [1].
Another approach combines buprenorphine management with a mobile app that offers CBT (cognitive behavioral therapy) and tracks patient progress. A study published in Substance Abuse Treatment, Prevention, and Policy in February 2025 followed 27 participants with moderate to severe opioid use disorder over a 12-week program. The findings showed that this virtual setup boosted patient engagement by removing barriers like transportation issues and scheduling conflicts [1].
For patients who don’t have reliable internet or video capabilities, audio-only models provide a practical alternative. Treatment is delivered over the phone, and current SAMHSA and DEA guidelines allow buprenorphine to be prescribed this way, ensuring patients don’t face interruptions in care.
These telehealth delivery models highlight the importance of streamlined workflows and dependable digital tools to support MAT programs effectively.
A successful telehealth MAT program depends on several key factors: flexible scheduling, remote informed consent, proper documentation, and effective coordination with pharmacies. Telehealth appointments, typically lasting about 30 minutes, help reduce wait times and make scheduling more manageable for both patients and providers.
Pharmacy coordination is another critical piece. Providers must ensure that local pharmacies are ready to dispense buprenorphine in line with telehealth prescribing rules, even when supply challenges arise.
Digital platforms like Opus Behavioral Health EHR play a vital role in enabling smooth workflows, ensuring compliance, and making care coordination more efficient.
When telehealth MAT programs operate without an integrated EHR, staff often face fragmented systems that waste time and increase the risk of errors.
Managing video visits, prescriptions, and clinical notes across separate platforms can lead to missed details and inefficiencies. Integrated EHR systems solve this by bringing clinical data, communications, and compliance protocols together in one place, creating smoother workflows.
The potential of telehealth MAT programs is fully realized when integrated with an EHR system. Key tools like e-prescribing, lab integration, and documentation capabilities play a vital role in improving efficiency and care delivery.
E-prescribing: Providers can send buprenorphine prescriptions directly to local pharmacies as soon as a virtual induction is complete.
Lab integration: Urine drug screen orders and results are automatically added to the patient’s chart, ensuring compliance and ongoing monitoring.
Other features have shown measurable results. For instance, AI-powered documentation - such as the Copilot AI tool in Opus Behavioral Health EHR - automatically captures clinical notes during appointments, reducing charting time by up to 40% [6].
Meanwhile, automated SMS reminders have cut no-show rates by over 60% within three months [5].
"Having our EHR seamlessly connected with billing has eliminated the documentation gaps that used to cause claim denials. Our clinicians document naturally, and the system automatically captures everything needed for proper reimbursement." - Lisa Chen, Practice Administrator, Behavioral Health Center [6]
Outcomes tracking is another vital feature. Tools like AUDIT and DAST, embedded directly into the EHR, allow providers to monitor progress in real time. This helps identify trends and adjust care plans before patients disengage, improving overall treatment outcomes.
A unified patient record is the cornerstone of an effective telehealth MAT program. By integrating virtual visits, lab results, and pharmacy data into a single chart, care teams can instantly access the full picture, enabling better coordination and safer care.
Interoperability also plays a key role in regulatory compliance. For example, EHRs with built-in PDMP checks ensure that these safety steps are completed as part of the prescribing process, rather than relying on manual reminders [4].
"Compliance that depends on memory is compliance that fails." - Mira Gwehn Revilla, Curogram [5]
The table below highlights how telehealth MAT services align with EHR requirements:
|
Service |
Telehealth-Appropriate |
In-Person Required |
EHR/Tech Requirement |
|---|---|---|---|
|
Intake & Screening |
✅ |
- |
Secure digital forms & video |
|
Buprenorphine Maintenance |
✅ |
- |
E-prescribing & PDMP integration |
|
Counseling & Groups |
✅ |
- |
HIPAA-compliant video |
|
Long-acting Injectables |
- |
✅ |
Hybrid scheduling & clinical notes |
|
Urine Drug Screens |
- |
✅ |
Lab integration & results tracking |
|
Methadone Dosing |
- |
✅ |
Inventory & dispensing integration |
For patients with co-occurring mental health conditions, interoperability becomes even more critical.
A single, unified record that captures both substance use and behavioral health data allows providers to treat the whole person without requiring patients to repeat their history at every step. This approach directly supports the article's broader focus on how integrated technology can elevate the delivery of MAT programs.
Even though telehealth MAT has shown clear clinical benefits and safety, several real-world obstacles limit its broader adoption.
For starters, many patients lack access to the necessary technology, such as smartphones with video capabilities, reliable internet, or sufficient cellular data for regular virtual appointments [2]. This issue is especially pronounced for individuals in shelters or shared housing, where finding a private space for confidential medical calls can be nearly impossible [2].
Pharmacy-related challenges also pose significant hurdles.
Even if a provider successfully conducts a virtual induction and electronically sends a buprenorphine prescription, local pharmacies may refuse to fill it due to supply restrictions. This leaves patients without access to critical medication, despite completing a successful medical visit [1].
"The primary barrier noted for virtual care delivery was the fulfillment of buprenorphine prescriptions from local pharmacies." - Springer Nature [1]
Clinicians have also raised concerns about the limitations of virtual care. Video consultations may not capture subtle but important patient cues, such as changes in mental state or other risk factors, which are easier to observe during in-person visits [2].
Tackling these barriers is essential to unlocking the full potential of telehealth in MAT programs. Enhanced EHR integration could also play a key role in streamlining telehealth workflows.
Telehealth offers a promising opportunity to close treatment gaps, particularly for patients in rural areas who would otherwise face long and difficult commutes for in-person care [1].
However, the same features that make telehealth convenient for some can exclude others. The digital divide often means that those with fewer resources - already underrepresented in MAT programs - may struggle to access telehealth services [2].
Some practical solutions could help. Offering multiple care options tailored to different patient needs is one approach.
For example, community organizations or shelters could set up private "telehealth booths" to provide a secure and confidential space for patients without privacy at home [2].
Additionally, subsidizing smartphones or data plans could help bridge the gap for patients who lack the necessary technology. Addressing these equity issues will require ongoing research and creative solutions to ensure telehealth MAT reaches everyone who needs it.
Although current studies highlight the short-term benefits of telehealth MAT, there’s limited data on long-term outcomes like patient retention and overall clinical success [1].
One critical area needing more attention is MAT induction for fentanyl users. These patients often face greater challenges when starting buprenorphine, and these difficulties can be even more pronounced in remote settings [1].
Given the prevalence of fentanyl in illicit drug supplies, addressing this issue is urgent.
"Patients who use fentanyl (knowingly or unknowingly) tend to encounter greater challenges inducting onto buprenorphine and therefore may encounter related difficulties with early engagement in a telehealth program." - Substance Abuse Treatment, Prevention, and Policy [1]
One potential solution could be combining telehealth prescribing with mobile apps that offer psychosocial support between clinical visits.
These tools could expand care access without adding to clinicians’ workloads [1]. However, the Ryan Haight Act, which requires an in-person visit for certain prescriptions, remains a policy barrier that needs to be addressed.
Ongoing research will be crucial for guiding policy changes and improving how telehealth MAT services are delivered in the future.
Telehealth has significantly improved MAT retention by eliminating logistical hurdles. In 2021, only 22% of adults with a past-year opioid use disorder received OUD medication [1], highlighting the pressing need for accessible solutions.
Telehealth bridges this gap by replacing lengthy, inflexible clinic visits with shorter, more convenient 20–30-minute sessions that fit seamlessly into patients' daily routines. This convenience also lays the groundwork for better integration with clinical workflows and more dependable operations.
One of telehealth's key strengths lies in its ability to integrate with clinical systems through EHRs. Platforms like Opus Behavioral Health EHR allow providers to conduct secure video visits directly from patient records. These systems automatically log sessions, handle e-prescribing, and track outcomes, all within a single streamlined workflow.
This approach not only simplifies care coordination but also ensures consistent clinical and billing practices while reducing data gaps.
While challenges remain - such as pharmacy supply issues, digital access inequalities, limited long-term research, and unresolved Ryan Haight Act policies- telehealth has already shown that it can deliver clinical outcomes on par with, or even better than, traditional in-person MAT care [1].
With advancements like browser-based video tools and integrated EHR platforms continuing to evolve, the foundation for broader adoption is already in place. The path forward will require collaboration to address these hurdles, but the progress so far is undeniable.
Recent studies indicate that telehealth within Medication-Assisted Treatment (MAT) programs can match the effectiveness of traditional in-person care. It provides greater access, boosts retention rates, and allows for flexible, patient-focused care.
This is especially true when telehealth is integrated into hybrid models that blend virtual and in-person treatment options.
Yes, healthcare providers will still be able to prescribe buprenorphine through telehealth in 2025, including during audio-only appointments.
They can issue an initial supply for up to six months, provided they review the patient’s prescription drug monitoring program (PDMP) data and follow all applicable federal and state regulations. It's important to verify the specific rules in your state to ensure everything is handled correctly.
To effectively support telehealth Medication-Assisted Treatment (MAT), certain features in an Electronic Health Record (EHR) system are essential. These include:
Integrated video conferencing: Enables seamless virtual consultations between providers and patients.
Secure messaging: Allows for confidential communication, ensuring patient privacy.
Digital forms for intake and consent: Simplifies the onboarding process by letting patients complete necessary paperwork online.
Self-scheduling tools: Empowers patients to book appointments at their convenience, reducing administrative burdens.
Streamlined workflows: Helps manage clinical notes, prescriptions, and lab results within a single, unified chart.
These tools not only simplify administrative processes but also support better compliance and more effective care delivery.